Management of Persistent Ground Glass Opacity Post-Pneumonia

Initial Assessment and Timeline

Expected resolution of post-pneumonic ground glass opacities occurs within 2-3 weeks after clinical symptom onset, progressing from patchy consolidation to strip-like opacity, then to grid-like thickening of interlobular septum with scattered patchy consolidations 1, 2

Obtain thin-section HRCT to characterize the ground glass opacity pattern and distribution, which is critical for narrowing differential diagnosis, and look for specific CT features including crazy-paving pattern, peripheral and lower lung predominance, centrilobular nodules with ground glass opacity, and traction bronchiectasis indicating fibrosis development 3, 4
Repeat respiratory pathogen testing, including atypical organisms and fungal antigens, and check inflammatory markers such as CRP, ESR, and procalcitonin to assess ongoing inflammation 1, 5
Lymphocyte count and differential, with absolute lymphocyte count <0.8 × 10⁹/L, warrants particular attention and repeat testing 1, 2

Organizing pneumonia, which may present with peripheral/peribronchovascular consolidation pattern, should be considered in the differential diagnosis 4, 6
Drug-induced pneumonitis, which requires temporal correlation with medication use, should be excluded in patients who have received antibiotics or other medications 4, 6
Pulmonary edema, which can be hydrostatic or permeability-related, should be considered and assessed with cardiac function and volume status evaluation 6
Hypersensitivity pneumonitis, which is suggested by centrilobular nodules with ground glass opacity, should be considered in patients with exposure history 4
Malignancy, including lymphangitic carcinomatosis or adenocarcinoma with lepidic growth, should be excluded in the differential diagnosis 5, 6

Proceed to bronchoscopy with bronchoalveolar lavage when ground glass opacity persists beyond 4 weeks or clinical deterioration occurs, as this provides both microbiologic and cytologic diagnosis 5
Transbronchial biopsy may assist in ruling out lymphangitic spread, organizing pneumonia, or chronic drug-induced changes, though the decision requires careful risk-benefit analysis 7

For persistent ground glass opacity without definitive diagnosis after initial workup, consider empiric corticosteroid trial if organizing pneumonia is suspected based on imaging pattern and clinical context 4, 7
Expect clinical improvement within 48-72 hours if organizing pneumonia is the underlying cause, and consider alternative immunosuppression or urgent tissue diagnosis in steroid-refractory cases 7

Serial HRCT at 4-6 week intervals should be performed to document progression, stability, or resolution, and progression or new symptoms mandate invasive diagnosis regardless of initial workup results 5

Do not delay bronchoscopy beyond 6-8 weeks in immunocompromised patients or those with progressive symptoms 5
Do not overlook medication history, as drug-induced pneumonitis can occur with common antibiotics and requires drug discontinuation 4, 6